News
-
-
COMMUNIQUÉ DE PRESSE
Green Logic Europe GmbH a Swiss-based investor focused on sustainable tree investments, has announced the completion of a majority share acquisition in Green Logic Schweiz AG
Green Logic Europe GmbH completes majority share acquisition in Green Logic Schweiz AG, strengthening position in sustainable tree investments market -
COMMUNIQUÉ DE PRESSE
Amundi Physical Metals plc: Final Terms
Amundi Physical Metals plc finalizes terms for issuance of Amundi Physical Gold ETC securities under its Precious Metal Linked ETC Securities Programme, with designated ETC Series and Tranche numbers, Metal Entitlement, Issue Date, Scheduled Maturity Date, and regulatory details -
-
COMMUNIQUÉ DE PRESSE
Hardman & Co Research on Duke Capital (DUKE): Taking Duke Capital to the next level
Hardman & Co Research provides an update on Duke Capital (DUKE) and its strategies to enhance returns through equity and debt optimization. Details include equity issue for growth and progress on a third-party capital model -
-
COMMUNIQUÉ DE PRESSE
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Bausch Health, Canada announces positive reimbursement recommendations for new acne treatment CABTREO, the first triple-combination topical therapy approved in Canada -
COMMUNIQUÉ DE PRESSE
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
Tharimmune, Inc. presents promising Phase 1 TH104 clinical data at The Liver Meeting® 2024, demonstrating significant correlation between blood levels and symptom relief in chronic liver disease patients -
COMMUNIQUÉ DE PRESSE
(Pr)CABTREO(MC) (phosphate de clindamycine, adapalène et gel de peroxyde de benzoyle), un traitement pour l'acné vulgaire, reçoit des recommandations de remboursement de l'Agence des médicaments du Canada et de l'INESSS, au Québec
Bausch Health, Canada Inc., une filiale de Bausch Health Companies Inc., annonce des recommandations positives de remboursement de CABTREO, un nouveau traitement topique triple pour l'acné vulgaire, par l'AMC et l'INESSS -
